Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM63B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRELID3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJB9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LEPROT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SUGT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FAM98B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPEB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDELR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DEPDC1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928826 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERMN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD2AP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFGEF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on